{Reference Type}: Review
{Title}: Role of rodent models in advancing precision medicine for Parkinson's disease.
{Author}: Simons E;Fleming SM;
{Journal}: Handb Clin Neurol
{Volume}: 193
{Issue}: 0
{Year}: 2023
暂无{DOI}: 10.1016/B978-0-323-85555-6.00002-3
{Abstract}: With a current lack of disease-modifying treatments, an initiative toward implementing a precision medicine approach for treating Parkinson's disease (PD) has emerged. However, challenges remain in how to define and apply precision medicine in PD. To accomplish the goal of optimally targeted and timed treatment for each patient, preclinical research in a diverse population of rodent models will continue to be an essential part of the translational path to identify novel biomarkers for patient diagnosis and subgrouping, understand PD disease mechanisms, identify new therapeutic targets, and screen therapeutics prior to clinical testing. This review highlights the most common rodent models of PD and discusses how these models can contribute to defining and implementing precision medicine for the treatment of PD.